Cargando…

Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation

Elevated levels of erythropoietin (EPO) are associated with an increased risk of death in renal transplant recipients (RTRs), but the underlying mechanisms remain unclear. Emerging data suggest that EPO stimulates production of the phosphaturic hormone fibroblast growth factor 23 (FGF23), another st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eisenga, Michele F., De Jong, Maarten A., Leaf, David E., Nolte, Ilja M., De Borst, Martin H., Bakker, Stephan J. L., Gaillard, Carlo A. J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356141/ https://www.ncbi.nlm.nih.gov/pubmed/32512806 http://dx.doi.org/10.3390/jcm9061737

Ejemplares similares

Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study
por: Eisenga, Michele F., et al.
Publicado: (2019)

Epoetin Beta and C‐Terminal Fibroblast Growth Factor 23 in Patients With Chronic Heart Failure and Chronic Kidney Disease
por: Eisenga, Michele F., et al.
Publicado: (2019)

Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study
por: De Jong, Maarten A, et al.
Publicado: (2020)

Association of different iron deficiency cutoffs with adverse outcomes in chronic kidney disease
por: Eisenga, Michele F., et al.
Publicado: (2018)

Association of Endogenous Erythropoietin Levels and Iron Status With Cognitive Functioning in the General Population
por: Ayerdem, Gizem, et al.
Publicado: (2022)

Iron deficiency, with and without anaemia, across strata of kidney function in kidney transplant recipients
por: Ayerdem, Gizem, et al.
Publicado: (2021)

Phosphate and fibroblast growth factor 23 in diabetes
por: van der Vaart, Amarens, et al.
Publicado: (2021)

Iron Deficiency and Nephrotoxic Heavy Metals: A Dangerous Interplay?
por: Rawee, Pien, et al.
Publicado: (2023)

Urinary prednisolone excretion is a determinant of serum hepcidin levels in renal transplant recipients
por: Eisenga, Michele F., et al.
Publicado: (2017)

Association of hepcidin‐25 with survival after kidney transplantation
por: Eisenga, Michele F., et al.
Publicado: (2016)

Switching iron sucrose to ferric carboxymaltose associates to better control of iron status in hemodialysis patients
por: Hofman, Jesse M. G., et al.
Publicado: (2018)

Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Type 2 Diabetes: a Bitter-Sweet Symphony
por: Yeung, Stanley M. H., et al.
Publicado: (2020)

Effect of Intravenous Ferric Carboxymaltose on Exercise Capacity After Kidney Transplantation (EFFECT-KTx): rationale and study protocol for a double-blind, randomised, placebo-controlled trial
por: Vinke, Joanna SJ, et al.
Publicado: (2023)

The EPO-FGF23 Signaling Pathway in Erythroid Progenitor Cells: Opening a New Area of Research
por: van Vuren, Annelies J., et al.
Publicado: (2019)

Iron deficiency after kidney transplantation
por: Vinke, Joanna Sophia J, et al.
Publicado: (2020)

Fibroblast Growth Factor 23, Glucose Homeostasis, and Incident Diabetes: Findings of 2 Cohort Studies
por: van der Vaart, Amarens, et al.
Publicado: (2023)

Vitamin C Depletion and All-Cause Mortality in Renal Transplant Recipients
por: Sotomayor, Camilo G., et al.
Publicado: (2017)

Urinary Potassium Excretion, Fibroblast Growth Factor 23, and Incident Hypertension in the General Population-Based PREVEND Cohort
por: Yeung, Stanley M. H., et al.
Publicado: (2021)

Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients
por: Hanudel, Mark R., et al.
Publicado: (2019)

Interleukin 6 and Development of Heart Failure With Preserved Ejection Fraction in the General Population
por: Chia, Yook Chin, et al.
Publicado: (2021)

Iron deficiency and cognitive functioning in kidney transplant recipients: findings of the TransplantLines biobank and cohort study
por: Vinke, Joanna Sophia J, et al.
Publicado: (2023)

Plasma Vitamin C and Cancer Mortality in Kidney Transplant Recipients
por: Gacitúa, Tomás A., et al.
Publicado: (2019)

Altered Gut Microbial Fermentation and Colonization with Methanobrevibacter smithii in Renal Transplant Recipients
por: Knobbe, Tim J., et al.
Publicado: (2020)

Type of proton‐pump inhibitor and risk of iron deficiency in kidney transplant recipients – results from the TransplantLines Biobank and Cohort Study
por: Douwes, Rianne M., et al.
Publicado: (2021)

Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure
por: van Breda, Fenna, et al.
Publicado: (2015)

The Role of Iron and Erythropoietin in the Association of Fibroblast Growth Factor 23 with Anemia in Chronic Kidney Disease in Humans
por: Bielesz, Bernhard, et al.
Publicado: (2020)

Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study
por: Binnenmars, S. Heleen, et al.
Publicado: (2022)

Plasma Copper Concentration Is Associated with Cardiovascular Mortality in Male Kidney Transplant Recipients
por: Yepes-Calderón, Manuela, et al.
Publicado: (2023)

Kidney Function-Dependence of Vitamin K-Status Parameters: Results from the TransplantLines Biobank and Cohort Studies
por: Kremer, Daan, et al.
Publicado: (2021)

Urinary Copper Excretion Is Associated with Long-Term Graft Failure in Kidney Transplant Recipients
por: Yepes-Calderón, Manuela, et al.
Publicado: (2023)

Chronic Use of Proton-Pump Inhibitors and Iron Status in Renal Transplant Recipients
por: Douwes, Rianne M., et al.
Publicado: (2019)

Transplantation of genetically engineered cardiac fibroblasts producing recombinant human erythropoietin to repair the infarcted myocardium
por: Ruvinov, Emil, et al.
Publicado: (2008)

Intracerebral transplantation of erythropoietin‐producing fibroblasts facilitates neurogenesis and functional recovery in an ischemic stroke model
por: Chou, Pin‐Chun, et al.
Publicado: (2019)

Decreased haemoglobin levels are associated with lower muscle mass and strength in kidney transplant recipients
por: Vinke, Joanna Sophia J., et al.
Publicado: (2022)

Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial
por: de Borst, Martin H., et al.
Publicado: (2017)

Reply to Janssen et al. Comment on “Kremer et al. Kidney Function-Dependence of Vitamin K-Status Parameters: Results from the TransplantLines Biobank and Cohort Studies. Nutrients 2021, 13, 3069”
por: Kremer, Daan, et al.
Publicado: (2022)

Sodium–Glucose Cotransporter 2 Inhibitors and Kidney Outcomes: True Renoprotection, Loss of Muscle Mass or Both?
por: Post, Adrian, et al.
Publicado: (2020)

Circulating Haptoglobin and Metabolic Syndrome in Renal Transplant Recipients
por: Minović, Isidor, et al.
Publicado: (2017)

Plasma versus Erythrocyte Vitamin E in Renal Transplant Recipients, and Duality of Tocopherol Species
por: Sotomayor, Camilo G., et al.
Publicado: (2019)

Posttransplant muscle mass measured by urinary creatinine excretion rate predicts long‐term outcomes after liver transplantation
por: Stam, Suzanne P., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_m37u26ngllbooqmu3669d09doh